Date Name Title Filing Type Shares Traded Price Total Held
Feb 14, 2014
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 15,000 $9.17 127,772
Nov 16, 2012
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 5,000 $152.00 127,772
May 18, 2010
Director
Director Form 4 Open market or private purchase of non-derivative or derivative security 5,000 $28.44 127,772
Nov 29, 2012
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 5,100 $176.54 128,676
Sep 19, 2013
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 21,179 $301.42 128,777
Dec 12, 2018
Director, President & CEO
Director, President & CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 129,013 -- 129,013
Dec 12, 2018
Director, President and CSO
Director, President and CSO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 129,013 -- 129,013
Nov 19, 2012
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 30,800 $160.59 129,200
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 129,902 -- 129,902
Jan 02, 2020
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 15,000 $24.41 130,095

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.